Bulk Manufacturer of Controlled Substances Application: PCAS-NANOSYN, LLC, 29336 [2015-12330]
Download as PDF
<![CDATA[
29336
Federal Register / Vol. 80, No. 98 / Thursday, May 21, 2015 / Notices
appropriate mitigation measures were
identified. The selected alternatives
were determined to be the
‘‘environmentally preferred’’ course of
action.
Dated: January 30, 2015.
Christine S. Lehnertz,
Regional Director, Pacific West Region.
[FR Doc. 2015–12376 Filed 5–20–15; 8:45 am]
BILLING CODE 4312–FF–P
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 337–TA–940]
Certain Snowmobiles With Engines
Having Exhaust TemperatureControlled Engine Technology and
Components Thereof; Termination of
an Investigation on the Basis of
Withdrawal of the Complaint
U.S. International Trade
Commission.
ACTION: Notice.
AGENCY:
Notice is hereby given that
the U.S. International Trade
Commission has determined not to
review the presiding administrative law
judge’s (‘‘ALJ’’) initial determination
(‘‘ID’’) (Order No. 11) granting the
complainant’s motion to terminate the
above-captioned investigation in its
entirety on the basis of withdrawal of
the complaint. The Commission has
terminated the investigation.
FOR FURTHER INFORMATION CONTACT:
Sidney A. Rosenzweig, Office of the
General Counsel, U.S. International
Trade Commission, 500 E Street SW.,
Washington, DC 20436, telephone (202)
708–2532. Copies of non-confidential
documents filed in connection with this
investigation are or will be available for
inspection during official business
hours (8:45 a.m. to 5:15 p.m.) in the
Office of the Secretary, U.S.
International Trade Commission, 500 E
Street SW., Washington, DC 20436,
telephone (202) 205–2000. General
information concerning the Commission
may also be obtained by accessing its
Internet server at https://www.usitc.gov.
The public record for this investigation
may be viewed on the Commission’s
electronic docket (EDIS) at https://
edis.usitc.gov. Hearing-impaired
persons are advised that information on
this matter can be obtained by
contacting the Commission’s TDD
terminal on (202) 205–1810.
SUPPLEMENTARY INFORMATION: The
Commission instituted this investigation
on December 24, 2014, based on a
complaint filed by Arctic Cat Inc. of
tkelley on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
20:28 May 20, 2015
Jkt 235001
Plymouth, MN (‘‘Arctic Cat’’). 79 FR
77526 (Dec. 24, 2014). The complaint
alleged violations of section 337 of the
Tariff Act of 1930, as amended, 19
U.S.C. 1337, in the importation into the
United States, the sale for importation,
and the sale within the United States
after importation of certain
snowmobiles with engines having
exhaust temperature-controlled engine
technology and components thereof by
reason of infringement of certain claims
of three United States patents. The
Commission’s notice of investigation
named as respondents Bombardier
´
Recreational Products, Inc. of Quebec,
Canada; and BRP US Inc. of Sturtevant,
Wisconsin.
On April 23, 2015, Arctic Cat filed an
unopposed motion to terminate the
investigation in its entirety based upon
withdrawal of the complaint. On April
24, 2015, the ALJ granted the motion as
an ID (Order No. 11).
No petitions for review were filed.
The Commission has determined not to
review the ID. The Commission has
terminated the investigation.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in the
Commission’s Rules of Practice and
Procedure (19 CFR part 210).
By order of the Commission.
Issued: May 18, 2015.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2015–12301 Filed 5–20–15; 8:45 am]
BILLING CODE 7020–02–P
Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on
December 11, 2014, PCAS-Nanosyn,
LLC, 3331–B Industrial Drive, Santa
Rosa, California 95403 applied to be
registered as a bulk manufacturer of the
following basic classes of controlled
substances:
Controlled substance
Oxycodone (9143) ........................
Oripavine (9330) ...........................
Oxymorphone (9652) ...................
Fentanyl (9801) ............................
Schedule
II
II
II
II
The company is a contract
manufacturer. At the request of the
company’s customers, it manufactures
derivatives of controlled substances in
bulk form.
Drug Enforcement Administration
Dated: May 15, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[Docket No. DEA–392]
[FR Doc. 2015–12330 Filed 5–20–15; 8:45 am]
DEPARTMENT OF JUSTICE
Bulk Manufacturer of Controlled
Substances Application: PCAS–
NANOSYN, LLC
ACTION:
Notice of application.
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Registered bulk manufacturers of
the affected basic classes and applicants
therefore may file written comments or
objections to the issuance of the
proposed registration in accordance
with 21 CFR 1301.33(a) on or before July
20, 2015.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODXL, 8701
Morrissette Drive, Springfield, Virginia
22152. Request for hearings should be
sent to: Drug Enforcement
Administration, Attention: Hearing
DATES:
BILLING CODE 4410–09–P
[Docket No. DEA–392]
Importer of Controlled Substances
Registration: Myoderm
ACTION:
Notice of registration.
Myoderm applied to be
registered as an importer of certain basic
classes of controlled substances. The
Drug Enforcement Administration
(DEA) grants Myoderm registration as an
importer of those controlled substances.
SUPPLEMENTARY INFORMATION: By notice
dated February 5, 2015, and published
in the Federal Register on February 11,
SUMMARY:
E:\FR\FM\21MYN1.SGM
21MYN1
]]>Agencies
[Federal Register Volume 80, Number 98 (Thursday, May 21, 2015)]
[Notices]
[Page 29336]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-12330]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: PCAS-
NANOSYN, LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes and
applicants therefore may file written comments or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before July 20, 2015.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/ODXL,
8701 Morrissette Drive, Springfield, Virginia 22152. Request for
hearings should be sent to: Drug Enforcement Administration, Attention:
Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Deputy Assistant Administrator of the DEA Office of Diversion
Control (``Deputy Assistant Administrator'') pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on
December 11, 2014, PCAS-Nanosyn, LLC, 3331-B Industrial Drive, Santa
Rosa, California 95403 applied to be registered as a bulk manufacturer
of the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Oxycodone (9143)........................... II
Oripavine (9330)........................... II
Oxymorphone (9652)......................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company is a contract manufacturer. At the request of the
company's customers, it manufactures derivatives of controlled
substances in bulk form.
Dated: May 15, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-12330 Filed 5-20-15; 8:45 am]
BILLING CODE 4410-09-P
